Epstein–Barr virus-associated post-transplant lymphoproliferative disease with central nervous system involvement after unrelated allogeneic hematopoietic stem cell transplantation

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Leukemia and Lymphoma

• Publication date

  2006-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/10428190500254208PMID 16321845
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunotherapy for Epstein – Barr Virus-Associated Tumors

  2004cited by this paper
• Treatment of Epstein-Barr virus lymphoproliferative disease after hematopoietic stem-cell transplantation with hydroxyurea and cytotoxic T-cell lymphocytes.

  2004cited by this paper
• Prompt versus preemptive intervention for EBV lymphoproliferative disease.

  2004cited by this paper
• High incidence of PTLD after non-T-cell-depleted allogeneic haematopoietic stem cell transplantation as a consequence of intensive immunosuppressive treatment

  2003cited by this paper
• Antiviral agent Cidofovir decreases Epstein–Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies

  2003cited by this paper
• Pre-emptive therapy with rituximab for prevention of Epstein–Barr virus-associated lymphoproliferative disease after hematopoietic stem cell transplantation

  2003cited by this paper
• Intrathecal Chemotherapy alone is Inadequate Central Nervous System Prophylaxis in Patients with Intermediate-grade Non-Hodgkin's Lymphoma

  2002cited by this paper
• Anti-CD20 Monoclonal Antibody (Rituximab) and Cidofovir as Successful Treatment of an EBV-Associated Lymphoma with CNS Involvement

  2001cited by this paper
• Identification of prognostic factors in 61 patients with posttransplantation lymphoproliferative disorders.

  2001cited by this paper
• CD‐20 expression in post‐transplant lymphoproliferative disorders: Treatment with Rituximab

  2000cited by this paper
• Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients.

  2000cited by this paper
• Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study.

  1999cited by this paper
• Anti-B-cell monoclonal antibody treatment of severe posttransplant B-lymphoproliferative disorder: prognostic factors and long-term outcome.

  1998cited by this paper

• Repurposing Licensed Drugs with Activity Against Epstein–Barr Virus for Treatment of Multiple Sclerosis: A Systematic Approach

  2025cites this paper
• Facial Paralysis From Post-Transplant Lymphoproliferative Disorder.

  2021cites this paper
• Frequency, characteristics, and outcome of PTLD after allo‐SCT: A multicenter study from the Spanish group of blood and marrow transplantation (GETH)

  2019cites this paper
• Primary Central Nervous System Post-transplant Lymphoproliferative Disorder Diagnosed by Peripheral Facial Nerve Palsy

  2018cites this paper
• Epstein‐Barr Virus Infection

  2016cites this paper
• Epstein-Barr virus-associated leukemic lymphoma after allogeneic stem cell transplantation.

  2016cites this paper
• Central nervous system EBV lymphoproliferative disorder in a patient with rhabdomyosarcoma

  2016cites this paper
• Relevance of Neutrophils and Neutrophil Extracellular Traps in Bronchiolitis Obliterans Syndrome of Patients Receiving Stem Cell Therapy

  2015cites this paper
• Epstein–Barr virus (EBV) load in cerebrospinal fluid and peripheral blood of patients with EBV‐associated central nervous system diseases after allogeneic hematopoietic stem cell transplantation

  2013cites this paper
• Intrathecal therapy with rituximab in central nervous system involvement of post-transplant lymphoproliferative disorder

  2013cites this paper
• Posttransplant Lymphoproliferative Disease after Pediatric Solid Organ Transplantation

  2013cites this paper
• Diagnosis and treatment of viral diseases in recipients of allogeneic hematopoietic stem cell transplantation

  2013cites this paper
• Post-transplant lymphoproliferative disorders

  2012cites this paper
• Epstein–Barr virus‐positive post‐transplant lymphoproliferative disorder of the central nervous system, after renal transplantation with a discrepancy in viral load between peripheral blood and cerebrospinal fluid

  2012cites this paper
• Primary central nervous system post-transplant lymphoproliferative disorders following allogeneic hematopoietic stem cell transplantation

  2012cites this paper
• Infectious, metabolic, and endocrine complications.

  2012cites this paper
• Successful treatment of post-transplant Epstein–Barr virus-related meningoencephalitis by intravenous rituximab monotherapy

  2012cites this paper
• Neurological Complications of Bone Marrow Transplantation in Lymphoma and Leukemia Patients

  2012cites this paper
• Isolated central nervous system Epstein–Barr virus‐associated post‐transplant lymphoproliferative disorder

  2011cites this paper
• Discrepancy in EBV-DNA load between peripheral blood and cerebrospinal fluid in a patient with isolated CNS post-transplant lymphoproliferative disorder

  2011cites this paper
• Isolated cerebral manifestation of Epstein–Barr virus‐associated post‐transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation: a case of clinical and diagnostic challenges

  2011influential citation
• Neurological complications after stem cell transplantation in children

  2011cites this paper
• Neurologic Complications of Hematopoietic Cell Transplantation

  2010cites this paper
• Neurologic complications of hematopoietic cell transplantation.

  2010cites this paper
• Primary central nervous system lymphoma.

  2010cites this paper
• Central nervous system infections in immunocompromised patients – update on diagnostics and therapy

  2009cites this paper
• Outcome of treatment of Epstein–Barr virus‐related post‐transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases

  2009cites this paper
• Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia

  2009cites this paper
• Primary central nervous system post‐transplant lymphoproliferative disorder presenting as cerebral hemorrhage after unrelated bone marrow transplantation

  2009cites this paper
• Abnormal conscious state and coma in transplant recipients.

  2008cites this paper
• Successful Treatment of EBV PTLD with CNS Lymphomas with the Monoclonal Anti-CD20 Antibody Rituximab

  2008cites this paper
• 36 – Primary Central Nervous System Lymphoma

  2007cites this paper
• Central nervous system post-transplant lymphoproliferative disorder despite negative serum and spinal fluid Epstein–Barr virus DNA PCR

  2007cites this paper
• Efficacy and tolerability of high‐dose methotrexate in central nervous system positive or relapsed lymphoproliferative disease following liver transplant in children

  2007cites this paper
• Neurologic complications of bone marrow and stem-cell transplantation in patients with cancer

  2007cites this paper